Xi Chen
- Immunology top 2%
- Immune cells in cancer 29
- Immune Cell Function and Interaction 11
- Immunotherapy and Immune Responses 11
- Oncology top 2%
- Cancer Immunotherapy and Biomarkers 37
- Cancer Research top 2%
- Molecular Biology top 2%
- PI3K/AKT/mTOR signaling in cancer 14
- Ubiquitin and proteasome pathways 9
- Immunology and Allergy top 5%
-
- Ferroptosis and cancer prognosis 9
- Lung Cancer Treatments and Mutations 9
- Cited by
- ImmunologyOncologyCancer Research
- Journals
- Cancer Research (10 papers)Frontiers in Immunology (8 papers)Frontiers in Pharmacology (7 papers)
- Partner nations
- ChinaUnited StatesSpain
In The Last Decade
Xi Chen
172 papers receiving 4.8k citations
Peers
Comparison fields: 5 of 131
- Immunology 1.2k
- Oncology 1.5k
- Cancer Research 789
- Molecular Biology 2.6k
- Immunology and Allergy 125
Countries citing papers authored by Xi Chen
This map shows the geographic impact of Xi Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xi Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xi Chen more than expected).
Fields of papers citing papers by Xi Chen
This network shows the impact of papers produced by Xi Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xi Chen. The network helps show where Xi Chen may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xi Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 5 | |
| 4 | 2023 | 1 | |
| 5 | 2023 | 2 | |
| 6 | 2023 | 4 | |
| 7 | 2022 | 2 | |
| 8 | 2021 | 4 | |
| 9 | 2020 | 51 | |
| 10 | 2018 | 98 | |
| 11 | 2017 | 38 | |
| 12 | 2014 | 34 | |
| 13 | 2014 | 98 | |
| 14 | 2014 | 8 | |
| 15 | 2014 | 44 | |
| 16 | 2013 | 167 | |
| 17 | 2012 | 46 | |
| 18 | 2010 | 48 | |
| 19 | 2008 | 131 | |
| 20 | 2006 | 120 |
About Xi Chen
Xi Chen is a scholar working on Oncology, Immunology and Molecular Biology, having authored 182 papers that have together received 4.8k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (37 papers), Immune cells in cancer (29 papers), PI3K/AKT/mTOR signaling in cancer (14 papers), Immune Cell Function and Interaction (11 papers), Immunotherapy and Immune Responses (11 papers), Ubiquitin and proteasome pathways (9 papers), Ferroptosis and cancer prognosis (9 papers) and Lung Cancer Treatments and Mutations (9 papers). The work is most often cited by research in Immunology (1.2k citations), Oncology (1.5k citations) and Cancer Research (789 citations). Xi Chen has collaborated with scholars based in China, United States and Spain. Frequent co-authors include Ling Ding, Qiaojun He, Chunming Liu, Wen Zhang, Paul M. Evans, Xi He, Bo Yang, Guangwei Liu, Hongjie Guo and Michael A. McNutt. Their work appears in journals such as Cancer Research, Frontiers in Immunology, Frontiers in Pharmacology, Frontiers in Oncology and Cancers.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.